REVIEW PAPER
Salivary biomarkers of malignant transformation from proliferative verrucous leukoplakia to oral squamous cell carcinoma – narrative review
 
More details
Hide details
1
Department of Oral Medicine, Medical University, Lublin, Poland
 
2
Department of Laboratory Diagnostics, Medical Univeristy, Lublin, Poland
 
 
Corresponding author
Marlena Pedowska   

Department of Oral Medicine, Medical University, Lublin, Poland
 
 
 
KEYWORDS
TOPICS
ABSTRACT
Introduction and objective:
Proliferative verrucous leukoplakia (PVL) is a multifocal oral potentially malignant disorder with a 44–46% malignant transformation rate, requiring lifelong surveillance and repeated biopsy. Because tissue sampling is invasive and may incompletely represent a multifocal field, salivary biomarkers are being explored as non-invasive adjuncts. This review summarises the biomarker domains relevant to transformation in PVL and distinguishes direct PVL evidence from evidence extrapolated from oral leukoplakia (OL) and OSCC.

Review methods:
A literature review was performed in PubMed, Scopus, and Web of Science to January 2026, combining terms for PVL, oral potentially malignant disorders, OSCC, saliva, biomarkers, microRNA, proteomics, microbiome, and liquid biopsy. Original studies, systematic reviews, and meta-analyses were considered. Publications lacking accessible full text or relevance to the biomarker domains were excluded.

Brief description of the state of knowledge:
Direct PVL-specific salivary evidence is limited to three areas: interleukin-6, elevated in PVL and correlating with the extent of verrucous areas; discovery-stage proteomic candidates (CALR, RACK1, YWHAQ); and comparative saliva microbiome data. Evidence for other protein markers and microRNA signatures is largely extrapolated from OL and OSCC.

Summary:
Salivary biomarkers are promising non-invasive adjuncts, but none are validated to replace clinical examination, site-directed biopsy, or histopathological assessment in PVL. Candidate panels require standardised pre-analytical protocols, control of confounders such as periodontal disease, and prospective multicentre validation. Until then, careful surveillance with targeted biopsy remains the standard of care.
PEER REVIEW INFORMATION
Article has been screened for originality
REFERENCES (21)
1.
Warnakulasuriya S, Kujan O, Aguirre-Urizar JM, et al. Oral potentially malignant disorders: a consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer. Oral Dis. 2021;27(8):1862–1880. https://doi.org/10.1111/odi.13....
 
2.
Ramos-García P, González-Moles MÁ, Mello FW, et al. Malignant transformation of oral proliferative verrucous leukoplakia: a systematic review and meta-analysis. Oral Dis. 2021;27(8):1896–1907. https://doi.org/10.1111/odi.13....
 
3.
Palaia G, Bellisario A, Pampena R, et al. Oral proliferative verrucous leukoplakia: progression to malignancy and clinical implications. Systematic review and meta-analysis. Cancers (Basel). 2021;13(16):4085. https://doi.org/10.3390/cancer....
 
4.
Thompson LDR, Fitzpatrick SG, Müller S, et al. Proliferative verrucous leukoplakia: an expert consensus guideline for standardized assessment and reporting. Head Neck Pathol. 2021;15(2):572–587. https://doi.org/10.1007/s12105....
 
5.
Cerero-Lapiedra R, Baladé-Martínez D, Moreno-López LA, et al. Proliferative verrucous leukoplakia: a proposal for diagnostic criteria. Med Oral Patol Oral Cir Bucal. 2010;15(6):e839–e845. https://doi.org/10.4317/medora....
 
6.
Carrard VC, Brouns EREA, van der Waal I. Proliferative verrucous leukoplakia; a critical appraisal of the diagnostic criteria. Med Oral Patol Oral Cir Bucal. 2013;18(3):e411–e413. https://doi.org/10.4317/medora....
 
7.
Liew YX, Kadir K, Phan CW, et al. Salivary biomarkers: effective diagnostic tool for oral leukoplakia and oral squamous cell carcinoma. Oral Dis. 2024;30(6):3591–3599. https://doi.org/10.1111/odi.14....
 
8.
Naito Y, Honda K. Liquid biopsy for oral cancer diagnosis: recent advances and challenges. J Pers Med. 2023;13(2):303. https://doi.org/10.3390/jpm130....
 
9.
Zhang X, Li B. Updates of liquid biopsy in oral cancer and multiomics analysis. Oral Dis. 2023;29(1):51–61. https://doi.org/10.1111/odi.14....
 
10.
Patel A, Patel S, Patel P, Tanavde V. Saliva based liquid biopsies in head and neck cancer: how far are we from the clinic? Front Oncol. 2022;12:828434. https://doi.org/10.3389/fonc.2....
 
11.
Rashid S, Puttagunta P, Pamulapati S, et al. Leveraging saliva for insights into head and neck cancer. Int J Mol Sci. 2024;25(24):13514. https://doi.org/10.3390/ijms25....
 
12.
Villa A, Villa C, Abati S. Oral cancer and oral erythroplakia: an update and implication for clinicians. Aust Dent J. 2011;56(3):253–256. https://doi.org/10.1111/j.1834....
 
13.
Bagan L, Sáez GT, Tormos MC, et al. Salivary and serum interleukin-6 levels in proliferative verrucous leukoplakia. Clin Oral Investig. 2016;20(4):737–743. https://doi.org/10.1007/s00784....
 
14.
Khijmatgar S, Yong J, Rübsamen N, et al. Salivary biomarkers for early detection of oral squamous cell carcinoma (OSCC) and head/neck squamous cell carcinoma (HNSCC): a systematic review and network meta-analysis. Jpn Dent Sci Rev. 2024;60:32–39. https://doi.org/10.1016/j.jdsr....
 
15.
Benito-Ramal E, Egido-Moreno S, González-Navarro B, et al. Role of selected salivary inflammatory cytokines in the diagnosis and prognosis of oral squamous cell carcinoma. A systematic review and meta-analysis. Med Oral Patol Oral Cir Bucal. 2023;28(5):e474–e486. https://doi.org/10.4317/medora....
 
16.
Umapathy VR, Natarajan PM, Swamikannu B. Review insights on salivary proteomics biomarkers in oral cancer detection and diagnosis. Molecules. 2023;28(13):5283. https://doi.org/10.3390/molecu....
 
17.
Arroyo E, Pérez Sayáns M, Bravo SB, et al. Identification of proteomic biomarkers in proliferative verrucous leukoplakia through liquid chromatography with tandem mass spectrometry. Lab Invest. 2023;103(10):100222. https://doi.org/10.1016/j.labi....
 
18.
Intini R, Balsells S, Bagan L, et al. Comparative analysis of oral microbiome in saliva samples of oral leukoplakia, proliferative leukoplakia and oral squamous cell carcinoma. Front Oral Health. 2025;6:1600090. https://doi.org/10.3389/froh.2....
 
19.
Świątkowski W, Bakiera A, Rahnama-Hezavah M, et al. The oral microbiota change in oral cancer – a preliminary study. Ann Agric Environ Med. 2025;32(3):353–360. https://doi.org/10.26444/aaem/....
 
20.
Kaunein N, Ramani RS, Koo K, et al. A systematic review of microRNA signatures associated with the progression of leukoplakia with and without epithelial dysplasia. Biomolecules. 2021;11(12):1879. https://doi.org/10.3390/biom11....
 
21.
Roi A, Boia S, Rusu LC, et al. Circulating miRNA as a biomarker in oral cancer liquid biopsy. Biomedicines. 2023;11(3):965. https://doi.org/10.3390/biomed....
 
eISSN:1898-2263
ISSN:1232-1966
Journals System - logo
Scroll to top